- Home
- RAPT vs SANG Comparison
RAPT vs SANG Comparison
Compare RAPT & SANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- SANG
- Stock Information
- Founded
- RAPT 2015
- SANG 1984
- Country
- RAPT United States
- SANG Canada
- Employees
- RAPT N/A
- SANG N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- SANG Computer Software: Programming Data Processing
- Sector
- RAPT Health Care
- SANG Technology
- Exchange
- RAPT Nasdaq
- SANG Nasdaq
- Market Cap
- RAPT 194.2M
- SANG 194.3M
- IPO Year
- RAPT 2019
- SANG 2021
- Fundamental
- Price
- RAPT $13.18
- SANG $5.71
- Analyst Decision
- RAPT Buy
- SANG
- Analyst Count
- RAPT 5
- SANG 0
- Target Price
- RAPT $33.60
- SANG N/A
- AVG Volume (30 Days)
- RAPT 117.5K
- SANG 2.2K
- Earning Date
- RAPT 08-07-2025
- SANG 11-05-2025
- Dividend Yield
- RAPT N/A
- SANG N/A
- EPS Growth
- RAPT N/A
- SANG N/A
- EPS
- RAPT N/A
- SANG N/A
- Revenue
- RAPT N/A
- SANG $238,264,000.00
- Revenue This Year
- RAPT N/A
- SANG N/A
- Revenue Next Year
- RAPT N/A
- SANG $2.38
- P/E Ratio
- RAPT N/A
- SANG N/A
- Revenue Growth
- RAPT N/A
- SANG N/A
- 52 Week Low
- RAPT $5.67
- SANG $4.08
- 52 Week High
- RAPT $26.56
- SANG $7.99
- Technical
- Relative Strength Index (RSI)
- RAPT 63.64
- SANG 48.19
- Support Level
- RAPT $11.19
- SANG $5.47
- Resistance Level
- RAPT $13.66
- SANG $6.26
- Average True Range (ATR)
- RAPT 0.75
- SANG 0.11
- MACD
- RAPT 0.19
- SANG -0.02
- Stochastic Oscillator
- RAPT 86.53
- SANG 32.10
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.